ReGen Factor Commence Cosmetic Trials
ReGen Factor commenced stage 1 cosmetic trials to prove the effectiveness of PepFactor Scalp for hair regrowth. The test will be conducted in accordance with stringent FDA regulations. This cosmetic trial is set to be completed by the end April 2021. The double blind trials will be conducted in 4 separate sites. Three of the sites are situated in the USA and one site in Australia. The aim of this study is to prove the effectiveness of PepFactor Scalp for the treatment of Androgynous Alopecia in both men and women.
